Few studies investigated sex-related differences in care consumption after dialysis initiation. Therefore, the aim of this study was to compare the care trajectory in the first year after dialysis start between men and women by taking into account the context of dialysis initiation. All patients who started dialysis in France in 2015 were included. Clinical data of patients and context of dialysis initiation were extracted from the Renal Epidemiology and Information Network (REIN) registry. Data on care consumption in the first year after dialysis start came from the French national health data system (SNDS): hospital stays <24h, hospital stays to prepare or maintain vascular access, hospital stays >24h for kidney problems and hospital stays >24h for other problems, and consultations with a general practitioner. Variables were compared between men and women with the χ2 test and Student's or Welch t-test and logistic regression models were used to identify the factors associated with care consumption after dialysis start. The analysis concerned 8,856 patients (36% of women). Men were less likely to have a hospital stays >24h for kidney problems than women (OR = 0.8, 95% CI = [0.7-0.9]) and less general practitioner consultations (OR = 0.8, 95% CI = [0.8-0.9]), in the year after dialysis initiation, after adjustment on patient's characteristics. Moreover, hospital stays for vascular access preparation or maintenance were longer in women than men (median duration: 2 days [0-2] vs. 1 day [0-2], p < 0.001). In conclusion, despite greater comorbidities in men, this study found few differences in post-dialysis care trajectory between men and women.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501619 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0289134 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Dialysis decision in critically ill patients in intensive care unit.
Acute Crit Care
February 2025
Department of Nephrology, Pusan National University School of Medicine, Yangsan, Korea.
The 2012 Kidney Disease Improving Global Outcomes guidelines clearly define emergent indications for kidney replacement therapy; however, whether dialysis should be initiated in critically ill patients without these indications remains unclear. This review briefly summarizes the results of recent landmark trials and discusses their limitations originating from a criteria-based approach at a single time point. Moreover, a personalized approach based on each patient's demand-capacity balance and its future benefits as a platform for kidney support therapy in critically ill patients are discussed.
View Article and Find Full Text PDFA Case Report of Herpes Simplex Virus Associated Peritoneal Dialysis Peritonitis With Novel Use of Intraperitoneal Acyclovir.
Kidney Med
April 2025
Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Viral etiologies, such as herpes simplex virus (HSV), for peritonitis can be misclassified as culture negative peritonitis because of poor accessibility of viral testing in the effluent fluid. Inaccurate diagnosis and subsequent ineffective treatment can lead to unnecessary catheter removal for presumed refractory peritonitis. Here, we report a 73-year-old woman with a history of genital HSV-2 on continuous cyclic peritoneal dialysis who presented with HSV-2 related peritonitis.
View Article and Find Full Text PDFThe Use of Nocturnal Home Hemodialysis in Sickle Cell Disease.
Hemodial Int
March 2025
Division of Nephrology, University Health Network, Toronto, Ontario, Canada.
Introduction: Despite being a rare cause of end-stage kidney disease (ESKD), sickle cell disease has broad kidney implications. Patients with both sickle cell disease and ESKD are at a greater risk of adverse events including mortality; while these patients can be managed with hemodialysis (HD), the use of nocturnal HD in sickle cell disease has not been previously described.
Methods: Here, we report a patient with sickle cell disease and ESKD who transitioned from conventional HD to nocturnal home HD.
[Early conversion to belatacept post-transplantation: state of the art and expert opinion].
Nephrol Ther
March 2025
Néphrologie, hémodialyse, aphérèse et transplantation, CHU Grenoble Alpes, La Tronche, France
Article Synopsis
- The standard immunosuppressive regimen after organ transplantation typically includes drugs like tacrolimus, mycophenolic acid, and corticosteroids, which can cause side effects like kidney damage.
- Belatacept offers a promising alternative by blocking a key costimulation pathway, showing improved kidney function and reduced donor-specific antibodies in early studies, despite a higher risk of acute rejections.
- Research highlights the benefits of converting to belatacept within the first six months after kidney transplantation, while also emphasizing the need for careful monitoring of rejection and infection risks.
Ethylene Glycol Poisoning Complicated by Cardiac Arrest and a Raised Lactate Gap: A Case Report.
Cureus
February 2025
Critical Care Medicine, James Cook University Hospital, NHS, Middlesbrough, GBR.
Ethylene glycol, a common component in automotive antifreeze and various household and industrial products, poses significant health risks upon ingestion, whether accidental or intentional. Characterized by severe metabolic acidosis, calcium oxalate crystal formation, and diverse end-organ damage, ethylene glycol toxicity can be fatal, with a potentially lethal dose estimated at 1500 mg/kg. The parent compound is osmotically active, leading to the production of harmful metabolites, such as glycolic and oxalic acids, which contribute to metabolic acidosis, nephrotoxicity, and cardiac toxicity.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!